Kynam Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Sell |
1,540,691
-262,059
| -15% | -$3.88M | 2.46% | 12 |
|
|
2025
Q1 | $32.3M | Hold |
1,802,750
| – | – | 2.71% | 14 |
|
|
2024
Q4 | $31.4M | Buy |
1,802,750
+431,239
| +31% | +$7.51M | 1.86% | 15 |
|
|
2024
Q3 | $19.2M | Sell |
1,371,511
-650,148
| -32% | -$9.1M | 1.47% | 16 |
|
|
2024
Q2 | $16.6M | Buy |
2,021,659
+21,659
| +1% | +$178K | 1.28% | 13 |
|
|
2024
Q1 | $15.4M | Hold |
2,000,000
| – | – | 1.61% | 13 |
|
|
2023
Q4 | $18M | Buy |
2,000,000
+1,042,498
| +109% | +$9.37M | 1.99% | 15 |
|
|
2023
Q3 | $8.56M | Sell |
957,502
-497,228
| -34% | -$4.45M | 1.4% | 16 |
|
|
2023
Q2 | $22.3M | Sell |
1,454,730
-108,865
| -7% | -$1.67M | 3.07% | 8 |
|
|
2023
Q1 | $35.2M | Buy |
1,563,595
+1,145,496
| +274% | +$25.8M | 4.54% | 7 |
|
|
2022
Q4 | $8.79M | Buy |
418,099
+1,370
| +0.3% | +$28.8K | 1.35% | 16 |
|
|
2022
Q3 | $10.3M | Sell |
416,729
-818,422
| -66% | -$20.2M | 2.16% | 14 |
|
|
2022
Q2 | $29.9M | Buy |
1,235,151
+364,233
| +42% | +$8.83M | 7.64% | 5 |
|
|
2022
Q1 | $22.4M | Buy |
870,918
+688,815
| +378% | +$17.8M | 7.28% | 5 |
|
|
2021
Q4 | $5.65M | Buy |
+182,103
| New | +$5.65M | 3.02% | 12 |
|